Download
s41375-021-01203-7.pdf 796,27KB
WeightNameValue
1000 Titel
  • Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia
1000 Autor/in
  1. Stanulla, Martin |
  2. Schaeffeler, Elke |
  3. Möricke, Anja |
  4. Buchmann, Swantje |
  5. Zimmermann, Martin |
  6. Igel, Svitlana |
  7. Schmiegelow, Kjeld |
  8. Flotho, Christian |
  9. Hartmann, Hans |
  10. Illsinger, Sabine |
  11. Sauerbrey, Axel |
  12. Junk, Stefanie V. |
  13. Schütte, Peter |
  14. Hinze, Laura |
  15. Lauten, Melchior |
  16. Modlich, Simon |
  17. Kolb, Reinhard |
  18. Rossig, Claudia |
  19. Schwabe, Georg |
  20. Gnekow, Astrid K. |
  21. Fleischhack, Gudrun |
  22. Schlegel, Paul Gerhard |
  23. Schünemann, Holger J. |
  24. Kratz, Christian P. |
  25. Cario, Gunnar |
  26. Schrappe, Martin |
  27. Schwab, Matthias |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-03-13
1000 Erschienen in
1000 Quellenangabe
  • 35(9):2650-2657
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1038/s41375-021-01203-7 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410596/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Long-term treatment with 6-thioguanine (6-TG) for pediatric acute lymphoblastic leukemia (ALL) is associated with high rates of hepatic sinusoidal obstruction syndrome (SOS). Nevertheless, current treatment continues to use short-term applications of 6-TG with only sparse information on toxicity. 6-TG is metabolized by thiopurine methyltransferase (TPMT) which underlies clinically relevant genetic polymorphism. We analyzed the association between hepatic SOS reported as a serious adverse event (SAE) and short-term 6-TG application in 3983 pediatric ALL patients treated on trial AIEOP-BFM ALL 2000 (derivation cohort) and defined the role of TPMT genotype in this relationship. We identified 17 patients (0.43%) with hepatic SOS, 13 of which with short-term exposure to 6-TG (P < 0.0001). Eight of the 13 patients were heterozygous for low-activity TPMT variants, resulting in a 22.4-fold (95% confidence interval 7.1-70.7; P ≤ 0.0001) increased risk of hepatic SOS for heterozygotes in comparison to TPMT wild-type patients. Results were supported by independent replication analysis. All patients with hepatic SOS after short-term 6-TG recovered and did not demonstrate residual symptoms. Thus, hepatic SOS is associated with short-term exposure to 6-TG during treatment of pediatric ALL and SOS risk is increased for patients with low-activity TPMT genotypes.
1000 Sacherschließung
lokal Adolescent [MeSH]
lokal Female [MeSH]
lokal Follow-Up Studies [MeSH]
lokal Hepatic Veno-Occlusive Disease/prevention
lokal Humans [MeSH]
lokal Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology [MeSH]
lokal Time Factors [MeSH]
lokal Acute lymphocytic leukaemia
lokal Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy [MeSH]
lokal Article
lokal Infant [MeSH]
lokal Male [MeSH]
lokal Antimetabolites, Antineoplastic/administration
lokal Prognosis [MeSH]
lokal Chemotherapy
lokal Thioguanine/administration
lokal Child [MeSH]
lokal Child, Preschool [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-3834-0727|https://frl.publisso.de/adhoc/uri/U2NoYWVmZmVsZXIsIEVsa2U=|https://frl.publisso.de/adhoc/uri/TcO2cmlja2UsIEFuamE=|https://frl.publisso.de/adhoc/uri/QnVjaG1hbm4sIFN3YW50amU=|https://frl.publisso.de/adhoc/uri/WmltbWVybWFubiwgTWFydGlu|https://frl.publisso.de/adhoc/uri/SWdlbCwgU3ZpdGxhbmE=|https://frl.publisso.de/adhoc/uri/U2NobWllZ2Vsb3csIEtqZWxk|https://frl.publisso.de/adhoc/uri/RmxvdGhvLCBDaHJpc3RpYW4=|https://frl.publisso.de/adhoc/uri/SGFydG1hbm4sIEhhbnM=|https://frl.publisso.de/adhoc/uri/SWxsc2luZ2VyLCBTYWJpbmU=|https://frl.publisso.de/adhoc/uri/U2F1ZXJicmV5LCBBeGVs|https://frl.publisso.de/adhoc/uri/SnVuaywgU3RlZmFuaWUgVi4=|https://frl.publisso.de/adhoc/uri/U2Now7x0dGUsIFBldGVy|https://frl.publisso.de/adhoc/uri/SGluemUsIExhdXJh|https://frl.publisso.de/adhoc/uri/TGF1dGVuLCBNZWxjaGlvcg==|https://frl.publisso.de/adhoc/uri/TW9kbGljaCwgU2ltb24=|https://frl.publisso.de/adhoc/uri/S29sYiwgUmVpbmhhcmQ=|https://frl.publisso.de/adhoc/uri/Um9zc2lnLCBDbGF1ZGlh|https://frl.publisso.de/adhoc/uri/U2Nod2FiZSwgR2Vvcmc=|https://frl.publisso.de/adhoc/uri/R25la293LCBBc3RyaWQgSy4=|https://orcid.org/0000-0001-5714-007X|https://frl.publisso.de/adhoc/uri/U2NobGVnZWwsIFBhdWwgR2VyaGFyZA==|https://frl.publisso.de/adhoc/uri/U2Now7xuZW1hbm4sIEhvbGdlciBKLg==|https://frl.publisso.de/adhoc/uri/S3JhdHosIENocmlzdGlhbiBQLg==|https://frl.publisso.de/adhoc/uri/Q2FyaW8sIEd1bm5hcg==|https://frl.publisso.de/adhoc/uri/U2NocmFwcGUsIE1hcnRpbg==|https://frl.publisso.de/adhoc/uri/U2Nod2FiLCBNYXR0aGlhcw==
1000 Hinweis
  • DeepGreen-ID: ab68b18403ca4f4f898161ef3975028e ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6443834.rdf
1000 Erstellt am 2023-04-27T11:00:09.455+0200
1000 Erstellt von 322
1000 beschreibt frl:6443834
1000 Zuletzt bearbeitet 2023-10-20T11:33:13.626+0200
1000 Objekt bearb. Fri Oct 20 11:33:13 CEST 2023
1000 Vgl. frl:6443834
1000 Oai Id
  1. oai:frl.publisso.de:frl:6443834 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source